Faster Rate of Initial Fluid Resuscitation in Severe Acute Pancreatitis Diminishes In-Hospital Mortality
Authors:
- Timothy B. GardnerTGTimothy B. Gardner
- Santhi Swaroop VegeSVSanthi Swaroop Vege
- Suresh T. ChariSCSuresh T. Chari
- Bret T. PetersenBPBret T. Petersen
- Mark D. TopazianMTMark D. Topazian
- Jonathan E. ClainJCJonathan E. Clain
- Randall K. PearsonRPRandall K. Pearson
- Michael J. LevyMLMichael J. Levy
- Michael G. SarrMSMichael G. Sarr
- 1 January 2009
- journal article
- Published by Elsevier in Pancreatology
- Vol. 9 (6) , 770-776
Abstract
We evaluated the impact of the initial intravenous fluid resuscitation rate within the first 24 h of presentation to the emergency room on important outcomes in severe acute pancreatitis. Patients presenting directly with a diagnosis of severe acute pancreatitis were identified retrospectively. Patients were divided into two groups - those who received >or=33% ('early resuscitation') and <33% ('late resuscitation') of their cumulative 72-hour intravenous fluid volume within the first 24 h of presentation. The primary clinical outcomes were in-hospital mortality, development of persistent organ failure, and duration of hospitalization. 17 patients were identified in the 'early resuscitation' group and 28 in the 'late resuscitation' group and there were no baseline differences in clinical characteristics between groups. Patients in the 'late resuscitation' group experienced greater mortality than those in the 'early resuscitation' group (18 vs. 0%, p < 0.04) and demonstrated a trend toward greater rates of persistent organ failure (43 vs. 35%, p = 0.31). There was no difference in the total amount of fluid given during the first 72 h. Patients with severe acute pancreatitis who do not receive at least one third of their initial 72-hour cumulative intravenous fluid volume during the first 24 h are at risk for greater mortality than those who are initially resuscitated more aggressively.Keywords
This publication has 21 references indexed in Scilit:
- Fluid Resuscitation in Acute PancreatitisClinical Gastroenterology and Hepatology, 2008
- The Effect of Age on Hospital Outcomes in Severe Acute PancreatitisPancreatology, 2008
- Acute Pancreatitis: Bench to the BedsideGastroenterology, 2007
- Practice Guidelines in Acute PancreatitisAmerican Journal of Gastroenterology, 2006
- Obesity Increases the Severity of Acute Pancreatitis: Performance of APACHE-O Score and Correlation with the Inflammatory ResponsePancreatology, 2006
- Acute pancreatitis and the role of histamine-2 receptor antagonists: a meta-analysis of randomized controlled trials of cimetidineEuropean Journal of Gastroenterology & Hepatology, 2002
- Octreotide 24‐h prophylaxis in patients at high risk for post‐ERCP pancreatitis: results of a multicenter, randomized, controlled trialAlimentary Pharmacology & Therapeutics, 2001
- The possible role of platelet-activating factor antagonist therapy in the management of severe acute pancreatitisBest Practice & Research Clinical Gastroenterology, 1999
- A randomised, double blind, multicentre trial of octreotide in moderate to severe acute pancreatitisGut, 1999
- A Clinically Based Classification System for Acute PancreatitisArchives of Surgery, 1993